Scarica l'app Stockscreener
12.84
2.34%
0.2772
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$12.56
Aprire:
$12.8
Volume 24 ore:
40,801
Relative Volume:
0.17
Capitalizzazione di mercato:
$352.86M
Reddito:
$30.43M
Utile/perdita netta:
$-18.15M
Rapporto P/E:
-18.60
EPS:
-0.69
Flusso di cassa netto:
$-9.08M
1 W Prestazione:
-1.65%
1M Prestazione:
-29.83%
6M Prestazione:
+2.10%
1 anno Prestazione:
+78.28%
Intervallo 1D:
$12.48
$13.21
Intervallo di 1 settimana:
$11.85
$13.60
Portata 52W:
$5.105
$19.22
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Nome
Clearpoint Neuro Inc
Settore
Industria
Telefono
(949) 900-6833
Indirizzo
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Confronta CLPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
12.84 | 352.86M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
126.24 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
97.11 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
370.37 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
93.07 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.71 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2023-10-24 | Iniziato | Stifel | Buy |
| 2023-02-16 | Ripresa | B. Riley Securities | Buy |
| 2022-04-05 | Ripresa | B. Riley Securities | Buy |
| 2021-03-18 | Iniziato | Lake Street | Buy |
| 2020-07-17 | Iniziato | B. Riley FBR | Buy |
Mostra tutto
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
ClearPoint Neuro (CLPT) to Release Quarterly Earnings on Tuesday - Defense World
MRI Interventions, Inc. Announces 2016 Fourth Quarter and Full Year Results - ACCESS Newswire
How To Trade (CLPT) - Stock Traders Daily
What is B. Riley’s Forecast for CLPT FY2025 Earnings? - Defense World
Taylor Frigon Capital Management LLC Sells 162,551 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen - Seeking Alpha
ClearPoint Neuro’s Earnings Call Highlights Robust Growth - TipRanks
MRI Interventions, Inc. Announces 2016 Third Quarter and Nine Month Results - ACCESS Newswire
ClearPoint Neuro (NASDAQ:CLPT) Issues Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Misses Revenue Estimates - MSN
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2024 Earnings Call Transcript - Insider Monkey
ClearPoint Neuro Achieves Record Growth in 2024 - TipRanks
Clearpoint Neuro Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: ClearPoint Neuro Q4 2024 sees stock dip post-earnings - Investing.com India
ClearPoint Neuro Reports Record 2024 Revenue Growth - TipRanks
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results - ACCESS Newswire
ClearPoint Neuro Crushes Expectations With 76% Product Revenue Surge in Latest Earnings - StockTitan
ClearPoint Neuro Inc (CLPT) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
Clearpoint Neuro Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
ClearPoint Neuro (CLPT) Projected to Post Earnings on Wednesday - Defense World
(CLPT) Trading Report - Stock Traders Daily
The Power Shift: How Small Investors Rule ClearPoint Neuro - Elblog.pl
Power to the People: How Individual Investors Are Influencing ClearPoint Neuro - Zaman
While institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownership - Yahoo Finance
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 22.1% in January - MarketBeat
Solventum (NYSE:SOLV) and ClearPoint Neuro (NASDAQ:CLPT) Head-To-Head Review - Defense World
What Do Wall Street Analysts Think About ClearPoint Neuro Inc (NASDAQ: CLPT) Stock? - Stocks Register
Legato Capital Management LLC Lowers Stock Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
After Leaping 25% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - Simply Wall St
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025 - ACCESS Newswire
ClearPoint Neuro Sets Stage for Crucial 2024 Financial Review: What the Brain Tech Leader Will Reveal - StockTitan
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula - WICZ
Game-Changing Brain Drug Delivery Device Gets Major EU Regulatory Win - StockTitan
ClearPoint Neuro (NASDAQ:CLPT) Hits New 12-Month HighTime to Buy? - MarketBeat
CLS publishes half-year report JanuaryJune 2024 - Finansavisen
(CLPT) Investment Report - Stock Traders Daily
ClearPoint Neuro (NASDAQ:CLPT) Shares Up 8.5%Time to Buy? - MarketBeat
JPMorgan Chase & Co. Has $110,000 Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.0 - MSN
B. Riley Boosts ClearPoint Neuro (NASDAQ:CLPT) Price Target to $20.00 - MarketBeat
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target - MSN
B. Riley Raises ClearPoint Neuro (NASDAQ:CLPT) Price Target to $20.00 - Defense World
How to Take Advantage of moves in (CLPT) - Stock Traders Daily
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target By Investing.com - Investing.com UK
ClearPoint Neuro price target raised to $20 from $15 at B. Riley - Yahoo Finance
Clearpoint Neuro Inc Azioni (CLPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):